ask="3.47"
ask_size="8100"
average_daily_volume="153415"
bid="N/A"
bid_size="N/A"
book_value="0.74"
change="+0.02"
change_from_200_day_moving_average="0.25"
change_from_50_day_moving_average="0.12"
change_from_52_week_high="-0.86"
change_From_52_week_low="1.50"
change_in_percent="+0.68%"
close="2.96"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.11"
ebitda="-30.33M"
eps_estimate_current_year="-1.14"
eps_estimate_next_quarter="-0.23"
eps_estimate_next_year="-0.96"
ex_dividend_date="N/A"
float_shares="21613000"
high="2.98"
high_52_weeks="3.82"
last_trade_date="2/10/2017"
last_trade_price="2.96"
last_trade_size="370"
last_trade_time="4:00pm"
low="2.92"
low_52_weeks="1.46"
market_capitalization="101.08M"
moving_average_200_day="2.71"
moving_average_50_day="2.84"
name="Fate Therapeutics
Inc."
notes="N/A"
one_year_target_price="5.83"
open="2.93"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+9.37%"
percent_change_from_50_day_moving_average="+4.36%"
percent_change_from_52_week_high="-22.51%"
percent_change_from_52_week_low="+102.74%"
previous_close="2.94"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.96"
price_per_sales="22.56"
revenue="4.45M"
shares_outstanding="34148000"
short_ratio="3.95"
stock_exchange="NGM"
symbol="FATE"
volume="56159"
weeks_range_52="1.46 - 3.82"
